ReviewBMJ neurology open2024

Guillain-Barré syndrome and checkpoint inhibitor therapy: insights from pharmacovigilance data.

Andre Abrahao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.